Faculty

Kristen Kruszewski, PharmD, MBA, Director of Pharmacy Strategy, Geisinger, Danville, Pa.

Randy Braun, PharmD, Pharmacist Coordinator, Informatics and Automation, UNC Health, Chapel Hill, N.C.

Eric Marshall, BA, JD, Principal, Leavitt Partners and Executive Director, PDG

Shoshana Krilow, JD, SVP, Public Policy and Government Relations, Vizient (moderator)

Kavish Choudhary, PharmD, MS, Chief Pharmacy Officer, University of Utah Hospitals and Clinics, Salt Lake City, Utah

Disclosure of Relevant Financial Relationships:

Relevant Financial Relationships 

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

Eric Marshall, JD, speaker for this educational activity, is a consultant for the following companies:

AbbVie;Alexion; Alnylam; American Pharmacists Association (APhA); AmerisourceBergen; Apotex; Association for Accessible Medicines (AAM); AstraZeneca; Bayer; Biogen; Biomarin; Bristol-Myers Squibb; CardinalHealth; CVSHealth; Fresenius Kabi; Genentech; GlaxoSmithKline; Healthcare Distribution Alliance (HDA); Inmar; International Warehouse Logistics Association (IWLA); Johnson & Johnson; Merck; Novartis; Partnership for DSCSA Governance (PDG); Pfizer; Pharmaceutical Research and Manufacturers of America (PhRMA); Takeda; United Parcel Service (UPS); Upsher-Smith Laboratories; Viatris (formerly Mylan);

All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.